Literature DB >> 19664544

Mesial temporal sclerosis after posterior reversible encephalopathy syndrome.

Mariam S Aboian1, Mithri R Junna, Karl N Krecke, Elaine C Wirrell.   

Abstract

Neither intrathecal methotrexate nor posterior reversible encephalopathy syndrome has previously been reported to result in mesial temporal sclerosis. Described here is the case of a boy with no risk factors for mesial temporal sclerosis who presented with posterior reversible encephalopathy syndrome and partial complex seizures 8 days after initiation of intrathecal methotrexate for treatment of Burkitt lymphoma, and who ultimately progressed to intractable temporal lobe epilepsy due to left mesial temporal sclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664544     DOI: 10.1016/j.pediatrneurol.2009.03.007

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  PRES-ing for Answers About Long-Term Seizure Risk in Patients With Posterior Reversible Encephalopathy Syndrome.

Authors:  David Spencer
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

2.  A study on clinical and radiological features and outcome in patients with posterior reversible encephalopathy syndrome (PRES).

Authors:  Rahul R Singh; Nurdan Ozyilmaz; Simon Waller; Jean-Marie U-King-Im; Ming Lim; Ata Siddiqui; Manish D Sinha
Journal:  Eur J Pediatr       Date:  2014-04-16       Impact factor: 3.183

3.  Posterior reversible encephalopathy syndrome in a child with autoimmune lymphoproliferative syndrome: Case report and review of literature.

Authors:  Vaishnavi Chandramohan; Vinoth Ponnurangam Nagarajan; Muthamil Selvan Sathyamoorthi; Sathish Kumar; Chitrambalam Shanmugasundaram; Gokulakrishnan Periakaruppan; Julius Xavier Scott
Journal:  J Pediatr Neurosci       Date:  2012-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.